Clinical trialNCT03647800UnknownPhase 1Interventional

Study of APVO436 in Patients With AML or MDS

SponsorAptevo Research and Development LLCEnrollment136AMLMDS

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of California, San Francisco Medical Center
San Francisco, California, United States
Active, not recruiting
Colorado Blood Cancer Institute
Denver, Colorado, United States
Recruiting
University of Florida College of Medicine
Gainesville, Florida, United States
Recruiting
Sylvester Comprehensive Cancer Center/umhc
Miami, Florida, United States
Recruiting
the University of Kansas Clinical Research Center
Westwood, Kansas, United States
Recruiting
Roswell Park Cancer Institute
Buffalo, New York, United States
Active, not recruiting
the Ohio State University Wexner Medical Center/james Cancer Hospital
Columbus, Ohio, United States
Recruiting
Greenville Health System, Institute for Translational Oncology Research
Greenville, South Carolina, United States
Recruiting
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Recruiting
the University of Texas M.D. Anderson Cancer Center
Houston, Texas, United States
Gautam Borthakur, MBBS
Recruiting
University of Utah, Huntsman Cancer Institute
Salt Lake City, Utah, United States
Recruiting
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Active, not recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

APVO436

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Dec 2018
Primary completion: 15 Dec 2022
Completion: 15 Jun 2023
Last update posted: 10 Feb 2022
Registered enrollment: 136
Registry id: NCT03647800

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.